Collectively, we demonstrate, using the EAE model of autoimmunity, that the novel combined approach of concomitantly inhibiting TNFR1 whilst promoting TNFR2 signalling may achieve greater beneficial effects than either approach in isolation. This evidence concerns the gene TNFRSF1B and Autoimmunity.